VAERS reports by lot

Pfizer COVID-19 lot EL9231: VAERS reports

28 VAERS reports list lot EL9231 as a Pfizer COVID-19 vaccine, received between 2021-01-05 and 2022-12-31. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
28
Reports
14%
Marked serious
1
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)3534%
Neurological1817%
Musculoskeletal1413%
Gastrointestinal1312%
Dermatological (non-injection-site)77%
Respiratory44%
Injection-site / Local reaction44%
Cardiac / Cardiovascular33%
Autoimmune / Immune-mediated22%
Allergic / Anaphylactic22%
Psychiatric / Neuropsychiatric22%

Where reports came from

U.S. state of the reporter, where given (top 12).

Pennsylvania4
Georgia3
North Carolina2
Oklahoma2
California2
Minnesota2
Montana2
New York2
Arizona1
Illinois1
South Carolina1
New Jersey1

Reports by month received

2021-015
2021-026
2021-032
2021-042
2021-051
2021-063
2021-071
2021-083
2021-101
2021-111
2022-031
2022-051
2022-121

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.